The table below shows Connect Biopharma Holdings Ltd's income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Revenue
$64.00K
$26.03M
$0.00
-
-
Cost of revenue
-
-
-
-
-
Gross profit
-
-
-
-
-
R&D
$37.80M
$29.26M
$53.00M
$96.63M
$80.50M
SG&A
$20.34M
$19.23M
$16.05M
-
-
CNTB annual revenue (10-K history)
Connect Biopharma Holdings Ltd reported annual revenue of $64.00K for fiscal year 2025. That is down 99.8% from $26.03M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.